Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 14, 2002 - Issue 8
35
Views
7
CrossRef citations to date
0
Altmetric
Research Article

EXPERIENCE FROM A LONG-TERM CARCINOGENICITY STUDY WITH INTRAPERITONEAL INJECTION OF BIOSOLUBLE SYNTHETIC MINERAL FIBERS

, , , &
Pages 855-882 | Published online: 01 Oct 2008

  • Attia, M. A. 1985. Neoplastic and non-neoplastic lesions in aging rats with special reference to the functional morphology of the hyperplastic and neoplastic changes in the pituary gland. Arch. Toxicol. 57:77-83.
  • Bernstein, D. M., and Riego Sintes, J. M. 1999. Methods for the determination of the hazardous properties for human health of man made mineral fibres (MMMF). EUR 18748 EN. European Commission, Joint Research Centre, lspra, Italy
  • Bernstein, D. M., Morscheidt, C, Grimm, H. G., Thevenaz, P., and Teichert, U. 1996. Evaluation of soluble fibers using the inhalation biopersistence model, a nine-fibre comparison, lnhal. Toxicol. 8: 345-385.
  • Bernstein, D. M., Morscheidt, C., de Meringo, A., Schumm, M., Grimm, H. G., Teichert, U., Thevenaz, P., and Mellon, L. 1997. The biopersistence of fibers following inhalation and intratracheal instillation exposure. Ann. Occup. Hyg. 41(1):224-230.
  • Bernstein, D. M., Riego-Sintes, J. M., Ersboell, B. K., and Kunert, J. 2001. Biopersistence of synthetic mineral fibers as a predictor of chronic intraperitoneal injection tumor response in rats, lnhal. Toxicol. 13(10):851-875.
  • Commission Directive 97/691 EC of 5 December. 1997. Off. J. Eur. Commun. L 343/19-24, 13.12.97.
  • Cullen, R. T., Davis, J. M. G., Miller, B. G., and Clark, S. 2000. Tumorigenicity of cellulose fibres injected into the peritoneal cavity. IOM Research Report TM/00/01, May. Institute of Occupational Medicine, Edinburgh, UK.
  • Davis, J. M. G., Bolton, R. E., Miller, B. G., and Niven, K. 1991. Mesothelioma dose response following intraperitoneal injection of mineral fibres. Int. J. Exp. Pathol. 72:263-274.
  • de Meringo, A., Morscheidt, C., Thdohan, S., and Tiesler, H. 1994. In vitro assessment of biodurability: Acellular systems. Environ. Health Perspect. 102(suppl.5):47-53.
  • Draeger, U., Guldberg, M., and Christensen, V. 1991. Zur Genauigkeit der Bestimmung der Faserzahl in Probenmaterialien für in-vivo-Experimente. ZbI. Arbeitsmed. 41:269-271.
  • Hanton, D., Furtak, H., and Grimm, H. G. 1998. Preparation and handling conditions of MMVF for in vivo experiments. Aerosol Sci. Technol. 29:449-456.
  • IARC. 1988. Man-made mineral fibres and radon. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 43.
  • Kroes, R., Garbis-Berkvens, J. M., de Vries, T., and Nesselroy, J. H. J. 1981. Histopathological profile of a Wistar rat stock including a survey of the literature. J. Cerontol. 36:359-379.
  • Lambre, C., Schorsch, F., Blanchard, O., Richard, J., Boivin, J. C., Hanton, D., Grimm, H. G., and Morscheidt C. 1998. An evaluation of the carcinogenic Potential of five man-made vitreous fibers using the intraperitoneal test, lnhal. Toxicol. 10:995-1021.
  • Peto et al. 1980. Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments. IARC Monograph. Suppl. 2:311-426.
  • Pott, F., Blome, H., Bruch, J., Friedberg, K. D., Rödelsperger, K., and Woitowitz, H. J. 1990a. Einstufungsvorschlag für anorganische und organische Fasern. Arbeitsmed. Sozialmed. Präventivmed. (ASP) 25:463-466.
  • Pott, F., Schlipköter, H. W., Roller, M., Rippe, R. M., Germann, P. G., Mohr, U., and Bellmann, B. 1990b. Kanzerogenität von Glasfasern mit unterschiedlicher Beständigkeit (Carcinogenicity of glass fibres with different durability). ZbI. Hyg. 189:563-566.
  • Pott, F., Roller, M., Rippe, R. M., Germann, P.-G., and Bellmann, B. 1991. Tumors by the intraperitoneal and intrapleural routes and their significance for the classification of mineral fibres. In Mechanisms in fibre carcinogenesis, eds. R. C. Brown, J. A. Hoskins, and N. F. Johnson, vol. 2, pp. 547-565. Nato AST Series. New York: Plenum Press.
  • Roller, M., Pott, F., Kamino, K., Althoff, G. H., and Bellmann, B. 1994. Detection of inorganic fibre carcinogenicity with the intraperitoneal test-recent results and their validity. Workshop MMF, Paris, 3-4 February 1994.
  • Roller, M., Pott, F., Kamino, K., Althoff, G. H., and Bellmann, B. 1996. Results of current intraperitoneal carcinogenicity studies with mineral and vitreous fibres. Exp. Toxicol. Pathol. 48:3-12.
  • RyIe, P. R., Marling, R. J., Brennan, C, Begg, S. E., and Gopinath, C. 1995. Survival in rat carcinogenicity studies. A comparison of Wistar rats obtained from two sources. Poster at the International Congress of Toxicology-VII, Seattle, WA.
  • Scholze, H., and Conradt, R. 1987. An in vitro study of the chemical durability of siliceous fibres. Ann. Occup. Hyg. 31 (4B):683-692.
  • Stanton, M. F., Layard, M., Tegeris, A., Miller, E., May, M., and Kent, E. 1977. Carcinogenicity of fibrous glass: pleural response in the rat in relation to fibre dimensions. J. Natl. Cancer lnst. 58: 587-597.
  • Thelohan, S., and de Meringo, A. 1994. In vitro dynamic solubility test: Influence of various parameters. Environ. Health Perspect. 102(suppl. 5):91-96.
  • TRGS 905.1994. Bundesarbeitsblatt 6/94:56-57.
  • Vandenberghe, J. 1990. Life-span data and historical data in cardnogenicity testing in Wistar rats CrI: (WI) BR. Janssen Research Foundation, Department of Toxicology, Jansen Pharmaceutica N.V., 2340 Beerse, Belgium.
  • Walsh, K. M., and Poteracki, J. 1994. Spontaneous neoplasms in control Wistar rats. Fundam. Appl. Toxicol. 22:65-72.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.